In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.

Published Date: 09 Feb 2024

95% of participants responded overall in the small trial.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

An Examine More Into the Acceptance of CRISPR/Cas9 Gene Therapy for Sickle Cell Illness.

2.

healthy despite having advanced cancer.

3.

Neural networks and label-free microscopy enable accurate detection of pancreatic tumors

4.

Surgery may not be necessary to treat invasive breast cancer

5.

Oral drug combination extends progression-free survival in advanced ER-positive breast cancer


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot